THE USE OF MEDICAL CARBON DIOXIDE AS A CONTRAST AGENT IN AORTOARTERIOGRAPHY

dc.contributor.author	Tursunov Jakhongir Tojiboevich
dc.date.accessioned	2025-12-31T15:35:50Z
dc.date.issued	2021-12-02
dc.description.abstract	To study the possibility of clinical application of medical carbon dioxide as an alternative contrast agent for imaging the arteries of the lower extremities. During the period from December 2020 to July 2021, 23 patients aged 48 to 86 years (with an average of 69 years-old) underwent 18 aortoarteriographies using medical carbon dioxide as a contrast agent. Such use of medical carbon dioxide allows obtaining high-quality contrasting of the vascular canal and in some cases has an advantage over the use of water-soluble contrast agents.
dc.format	application/pdf
dc.identifier.uri	https://scholarexpress.net/index.php/wbph/article/view/318
dc.identifier.uri	https://asianeducationindex.com/handle/123456789/48779
dc.language.iso	eng
dc.publisher	Scholar Express Journals
dc.relation	https://scholarexpress.net/index.php/wbph/article/view/318/314
dc.rights	https://creativecommons.org/licenses/by-nc-nd/4.0
dc.source	World Bulletin of Public Health; Vol. 4 (2021): WBPH; 103-104
dc.source	2749-3644
dc.subject	medical carbon dioxide
dc.subject	water-soluble contrast agents
dc.subject	agent
dc.subject	underwent
dc.title	THE USE OF MEDICAL CARBON DIOXIDE AS A CONTRAST AGENT IN AORTOARTERIOGRAPHY
dc.type	info:eu-repo/semantics/article
dc.type	info:eu-repo/semantics/publishedVersion
dc.type	Peer-reviewed Article

item.page.files

pagination.showing.labelpagination.showing.detail

item.page.filesection.name: tojiboevich_2021_the_use_of_medical_carbon_dioxide_as_a_c.pdf
item.page.filesection.size: 84.28 KB
item.page.filesection.format: Adobe Portable Document Format